A carregar...
Antiangiogenic therapies in non-small-cell lung cancer
Angiogenesis is frequent in non-small-cell lung cancer (nsclc) and is associated with more aggressive disease. Many clinical trials have evaluated the addition of antiangiogenic therapy to standard therapies for patients with nsclc. Bevacizumab, a monoclonal antibody directed against serum vascular...
Na minha lista:
| Publicado no: | Curr Oncol |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Multimed Inc.
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6001774/ https://ncbi.nlm.nih.gov/pubmed/29910647 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3747/co.25.3747 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|